Secure Code Warrior and Okta Collaborate to Create New Solution to Secure Developer Workflows
Secure Code Warrior, the global, developer-driven security leader, today announced an exciting addition to the Okta Integration Network. Okta, the leading independent provider of identity, and Secure Code Warrior collaborated to deliver a new solution - the Secure Code Warrior (SCW) Connector for Okta Workflows, which enables organizations and developers to write secure code from the start of the software development lifecycle (SDLC).
Applying a security-first mindset, organizations can design an identity workflow that protects builds from the beginning of the life cycle, giving organizations the flexibility to only provide GitHub repo access to security proficient developers. This helps organizations promote a security first culture while the SCW Learning Platform enables developers to meet these standards and requirements. Organizations have implemented this solution across their application, security and engineering teams to provide this additional layer of security.
Preventing insecure code and ensuring better access control during software development remains a significant need for industries across all verticals. Meanwhile, developers recognize the importance of delivering secure software applications but face competing priorities. According to SCW’s recently released “The State of Developer-Driven Security Survey, 2022”, 67% knowingly left vulnerabilities and exploits in their code, with a lack of time and a cohesive approach cited as the two main barriers to the adoption of secure coding practices.
“This new solution will help organizations reduce the risk of developers committing insecure code by ensuring that employees are up to date on the latest vulnerabilities and secure coding techniques. Through our work together with Okta on a security proficiency check, AppSec Managers can be confident that the team is committing secure code without moving developers out of their workflow. Now, leaders can focus on broad strategic efforts to improve the organization’s security posture without sacrificing quality or time.” said Pieter Danhieux, Co-founder and CEO, Secure Code Warrior.
“Okta Workflows provides a no-code, low-code approach to automating identity-centric processes at scale. As an early adopter of Workflows Connector Builder, we are excited to have the new Secure Code Warrior connector in the Okta Integration Network, which goes beyond SSO and provisioning to support advanced integration flows. Developers can be confident that their secure code knowledge is up to date and relevant to the code they are committing” said David Shackelford, Senior Director, Okta.
The Secure Code Warrior Connector for Okta Workflows utilizes key components of both companies’ technology platforms to benefit organizations and developers alike:
- Pre-configured actions enable developer teams to quickly build the desired workflows in a no-code/low code environment, without the hassle of getting into the complexities of API calls.
- Once the workflow is ready, it will run automatically and can be customized for frequency.
- Secure Code Warrior’s Learning Platform provides information on the developers’ assessment score and course completion status, giving teams the insights to determine their security skills when writing code.
- Organizations have the flexibility to only allow GitHub repo access to security proficient developers
Creating and automating secure developer workflows is now easier than ever thanks to this new industry solution from Secure Code Warrior and Okta. The Secure Code Warrior Connector for Okta Workflows is available at https://help.okta.com/wf/en-us/Content/Topics/Workflows/connector-reference/securecodewarrior/securecodewarrior.htm.
To learn more, visit www.securecodewarrior.com/blog/scw-connector-for-okta-workflows.
About Secure Code Warrior
Secure Code Warrior builds a culture of security-driven developers by giving them the skills to code securely. Our flagship Learning Platform delivers relevant skills-based pathways, hands-on missions, and contextual tools for developers to rapidly learn, build, and apply their skills to write secure code at speed. Established in 2015, Secure Code Warrior has become a critical component for over 450 enterprises including leading financial services, retail, and global technology companies across the world. Visit: www.securecodewarrior.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220602005007/en/
Contact information
Carolina Machado
+61 452 265 033
cmachado@securecodewarrior.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 14:00:00 EET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreement were not disclosed. “This new agreement builds upon our recent co-development collaboration with Acepodia, which has focused on the evaluation and selection
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 12:08:00 EET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 11:44:00 EET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 11:00:00 EET | Press release
Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE. “Insurance is an industry where the stakes of using AI are particularly high: the decisions can affect millions of people. Allianz and Anthropic both take that very seriously, and we look forward to working together to make insurance better for those w
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 08:00:00 EET | Press release
MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind, placebo-controlled study designed to confirm the promising efficacy signals and favorable safety profile previously observed in MH002’s Phase 2a studies. MH002, a rationally designed live microbial consortium, is the most advanced Live Biotherapeutic Product (LBP) of its kind, targeting disease-specific mechanisms through a synergistic combination of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
